Status:
COMPLETED
Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
Lead Sponsor:
AstraZeneca
Conditions:
Hormon Receptor Positive Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
This observational study in estrogen receptor positive early breast cancer patients is aimed to evaluate the patients' compliance to aromatase inhibitor (AI) therapy and to collect country-specific da...
Eligibility Criteria
Inclusion
- Postmenopausal females with estrogen receptor positive breast cancer that are currently treated with aromatase inhibitor (AI) medication
- Provision of subject informed consent
Exclusion
- If participating in any clinical trial, the subject cannot take part in this study.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01208779
Start Date
January 1 2011
End Date
November 1 2012
Last Update
July 17 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Vojvodina, Sremska Kamenica, Serbia
2
Research Site
Belgrade, Serbia